Keyphrases
Bezlotoxumab
5%
C.difficile Infection
14%
Clinical Outcomes
5%
Clinical Practice Guidelines
5%
Clostridioides Difficile
28%
Clostridium Difficile Infection
100%
COVID-19
6%
Difficile
24%
Epidemiology
8%
Healthcare
5%
Healthcare-associated Infections
9%
Hospital-onset
5%
Hospitalized Patients
10%
Infection Prevention
7%
Infection Rate
9%
Microbiota
5%
Placebo
7%
RBX2660
6%
Risk Factors
12%
Solid Organ Transplant Recipients
5%
United States
6%
Vancomycin
5%
Medicine and Dentistry
Clinical Trial
5%
Clostridium Difficile Infection
57%
Cohort Effect
12%
COVID-19
5%
Diarrhea
5%
Diseases
6%
Emergency Care
5%
Enzyme Immunoassay
5%
Healthcare Associated Infection
9%
Infection
40%
Infection Prevention
6%
Infection Rate
5%
Peptoclostridium difficile
17%
Placebo
5%
Prevalence
5%
Recurrent Disease
6%
Transplantation
8%
Vancomycin
6%